- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
4108
TAI
Week ended 07 Aug 2026
Weekly Investor Report
PhytoHealth Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
11.15 TWD
-1.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -12.6% below the Trend Line and sits at 2.2% of its 52-week range. The latest completed week returned -1.3%, after a -7.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
17
out of 100
Latest Close
11.15 TWD
7 Aug 2026
1W Return
-1.3%
latest completed week
4W Return
-7.1%
short-term follow-through
12W Return
-4.7%
quarterly tape
Trend Breadth
11.5%
6 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.3%
Latest completed week; four-week move -7.1%.
Indicator stack
6/19
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.92%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -12.6% below the Trend Line and sits at 2.2% of its 52-week range. The latest completed week returned -1.3%, after a -7.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.1% over four weeks, -4.7% over 12 weeks, and -12.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.48Latest activity-pressure read.
Pressure change-279.9%Four-week change in activity pressure.
Leadership-40.69Latest relative-leadership reading.
RS change0.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-37.7%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher6 of 2620 weeks finished lower.
Best week+10.3%Week of 22 May.
Worst week-3.9%Week of 29 May.
Latest week-1.3%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains4
Flat weeks0
Modest losses20
Sharp losses0
Recent vol3.9%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split17/33Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank40 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank10 / 13
Group average-3.1%
Trend breadth23.1%
Trend23.1%active weekly trend signals
MD53.8%positive activity pressure
RS7.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape15/100
Trend, activity pressure, participation, and risk combine to a 15/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 39.92%Next-week expectancy is negative with a 39.92% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 11.15 TWD | -1.3% | 12.76 TWD | 16.74 TWD | -0.48 | -40.69 | 990.3K | Off |
| 31 Jul 2026 | 11.30 TWD | -3.8% | 12.83 TWD | 16.82 TWD | -0.27 | -39.14 | 907.5K | Off |
| 24 Jul 2026 | 11.75 TWD | 0.4% | 12.90 TWD | 16.89 TWD | -0.03 | -38.30 | 857.1K | Off |
| 17 Jul 2026 | 11.70 TWD | -2.5% | 12.97 TWD | 16.96 TWD | -0.08 | -37.95 | 851.9K | Off |
| 10 Jul 2026 | 12.00 TWD | -2.8% | 13.04 TWD | 17.04 TWD | -0.13 | -40.90 | 1.3M | Off |
| 3 Jul 2026 | 12.35 TWD | 3.8% | 13.12 TWD | 17.11 TWD | -0.23 | -41.89 | 1.3M | Off |
| 26 Jun 2026 | 11.90 TWD | -0.8% | 13.18 TWD | 17.18 TWD | -0.29 | -42.10 | 1.1M | Off |
| 19 Jun 2026 | 12.00 TWD | -2.4% | 13.24 TWD | 17.24 TWD | -0.30 | -44.82 | 988.2K | Off |
| 12 Jun 2026 | 12.30 TWD | -3.1% | 13.32 TWD | 17.31 TWD | -0.16 | -41.48 | 1.2M | Off |
| 5 Jun 2026 | 12.70 TWD | 2.4% | 13.38 TWD | 17.36 TWD | -0.41 | -41.73 | 2.2M | Off |
| 29 May 2026 | 12.40 TWD | -3.9% | 13.42 TWD | 17.42 TWD | -0.79 | -43.62 | 1.6M | Off |
| 22 May 2026 | 12.90 TWD | 10.3% | 13.49 TWD | 17.47 TWD | -1.05 | -38.88 | 2.1M | Off |
| 15 May 2026 | 11.70 TWD | -3.3% | 13.55 TWD | 17.52 TWD | -1.40 | -43.88 | 1.2M | Off |
| 8 May 2026 | 12.10 TWD | -1.2% | 13.66 TWD | 17.59 TWD | -1.29 | -43.52 | 982.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.